Xeltis CEO Schutte on Building a Business Around Tech that Helps the Body Build New Blood Vessels

In this episode, Host Tom Salemi sits down with Eliane Schutte, CEO of Xeltis, to discuss a remarkable biomaterial designed to help the body grow its own living blood vessels. Schutte explains how the technology is being used for dialysis patients today and how it could eventually transform coronary bypass surgery, peripheral vascular care and even heart valve replacement. In the FOMO studio, Tom speaks with Katie Grant, VP of MR at Siemens Healthineers North America, about the global helium supply and why the MRI industry is working to reduce its reliance on the increasingly precious gas. They explore how new magnet designs could make MRI systems lighter, more accessible and easier to install in new locations. As always, we’ll open the podcast with the top stories from MassDevice in Newmarker’s Newsmakers, delivered by MassDevice Editor Chris Newmarker. This week, Chris covers Medtronic’s major investment in surgical robotics, Enovis’ acquisition of eCential Robotics, Stryker’s move to strengthen its shoulder portfolio, the rebranding of Johnson & Johnson MedTech, and job shifts at Zoll Medical. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:35) - Zoll Medical is closing a California facility(00:07:33) - Stryker to acquire ZuriMed to boost shoulder offerings(00:09:35) - Enovis to acquire eCential Robotics for €155 million, plans to bring surgical robot to market(00:11:58) - J&J MedTech is rebranding Shockwave Medical(00:14:06) - Medtronic invests $780M in two companies amid Street-beating Q2(00:17:10) - FOMO – The State of Helium in MR – Katie Clark, Siemens Healthineers(00:31:38) - Keynote Interview – Eliane Schutte, CEO, Xeltis